• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Natco Pharma Limited — Updates, 03-03-2026: Press Release

    03-03-2026 | 10:29 am

    NATCO Pharma, with Breckenridge, launched generic Pomalidomide Capsules (Pomalyst®) in the U.S. market. This drug had ~$3.2 billion annual US sales. NATCO expects 180 days of shared exclusivity, boosting its oncology portfolio.

    No comments yet. Be the first to comment!

    All announcements from Natco Pharma Limited